Rajesh bhushan English news | Rajesh bhushan, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug's supply on the firm's website respectively.Considering the emergency and unmet medical need for COVID -19 diseases, Central Drugs Standard Controller Orgsation (CDSCO) -- the office of DCGI had granted permission to manufacture and market remedisvir injection able formulation for restricted emergency use in the country for the treatment of patients with COVID-19 infection subject to various conditions and restrictions.In a press briefing Rajesh Bhushan, Officer on Special Duty at the Union Health Ministry said: "The DCGI has written two letters to the compes which are manufacturing these drugs and he made two specific suggestions. First, these compes have to put in place the 24/7 helpline where patients or their caregivers can contact these compes in case the drug is not available in the market or the drug is being overcharged. Second suggestion is that these compes have to put the details of the distribution network of their supply line on their website proactively, so that the confusion and anxiety subsides."Dr VG Som, DCGI, wrote a letter to all three domestic pharma giants and he stated: "You are advised to start a 24x7 helpline for patients and their families to contact the company in case the medicine is not available or higher prices being charged. Further, the details of the helpline can be widely advertised through your channels of communication.""In this connection, this office has received the representation raising concern regarding black marketing and overcharging of the drug remdesivir injection able formulation in the country," stated the letter in possession with ."You are therefore requested to upload the information on your website regarding the distributors and supply chain details along with quantities where remdesivir has been made available, so as to prevent black marketing and overcharging of the drug," read the letter adding that action taken in this matter may please be initiated to this office at the earliest.The Union Health Ministry in its Clinical Management Protocols for COVID-19 has allowed the use of remdesivir for restricted emergency use purposes in patients in the moderate stages of the COVID19 disease under "investigational therapies".According to the Bhushan, drugs regulator has also directed all drug controllers in the States and Union Territories to keep strict vigil to prevent the black marketing and sale of the anti-drug remdesivir injection above MRP.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Marathi Language Controversy

Maharashtra News

Mumbai Local

Weather Update

Mumbai Rains

Ahmedabad Plane Crash

Rajesh BhushanFOLLOW

Rajesh bhushan, Latest News

National :India's COVID-19 recovery rate at 62.72 pc: Health Ministry

India's COVID-19 recovery rate is increasing day by day and today it is 62.72 per cent, Rajesh Bhushan, Officer on Special Duty (OSD), Health Ministry said on Tuesday. ...

National :Progressive decline in daily growth rate of new COVID-19 cases: Health Ministry

The Union Health Ministry on Tuesday informed that the daily growth rate of newer coronavirus cases is declining each day. Till July 12, the Central government has recorded daily the growth rate for newer cases at 3.24 per cent. ...

National :86 pc COVID-19 cases in 10 states: Health Ministry

The majority of the COVID-19 cases in the country, close to 86 per cent, are confined to 10 states with Maharashtra and Tamil Nadu accounting for more than 50 per cent of them, Health Ministry said on Tuesday. ...

Health :ICMR plans national sero-survey to detect exposure to Covid-19

New Delhi, July 10 The Indian Council of Medical Research (ICMR) is planning to carry out a nationwide ... ...

National :COVID-19: Union Health Ministry to conduct another sero-surveillance across India

The Ministry of Health and Family Welfare is planning to conduct a nationwide sero-surveillance to evaluate the trend of COVID-19 among the population, the Central government informed on Thursday. ...

National :DCGI instructs pharma giants manufacturing remdesivir to upload details of drug's supply on firm's website

Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remeds ...